Key facts
- Notable investors include Qatar Science & Technology Park.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for RapidDx Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for RapidDx Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About RapidDx Biotech
Developer of molecular diagnostic testing technology intended to support rapid medical decision-making. The company focuses on rapid molecular diagnostics and AI-powered medical testing, combining laboratory and software capabilities to deliver fast test results, and applies advanced analysis to aid in disease detection and monitoring, enabling healthcare providers and clinical laboratories to obtain timely diagnostic information for patient assessment and treatment planning.
- Sector
- Healthcare
- HQ
- Doha, Qatar
- Founded
- 2025
- Website
- rapid-dx.com/
- Ownership
- Privately Held (backing)
RapidDx Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RapidDx Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RapidDx Biotech in its N-PORT filings yet. We sweep new filings monthly.